Lennart Hansson
#123,780
Most Influential Person Now
Lennart Hansson's AcademicInfluence.com Rankings
Lennart Hanssonphilosophy Degrees
Philosophy
#5704
World Rank
#8586
Historical Rank
Logic
#2936
World Rank
#4015
Historical Rank

Download Badge
Philosophy
Why Is Lennart Hansson Influential?
(Suggest an Edit or Addition)Lennart Hansson's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial (1998) (5865)
- Outcomes in hypertensive patients at high cardiovascular risk treated with regimens based on valsartan or amlodipine: the VALUE randomised trial (2004) (2115)
- Effect of angiotensin-converting-enzyme inhibition compared with conventional therapy on cardiovascular morbidity and mortality in hypertension: the Captopril Prevention Project (CAPPP) randomised trial (1999) (2032)
- Randomised trial of old and new antihypertensive drugs in elderly patients: cardiovascular mortality and morbidity the Swedish Trial in Old Patients with Hypertension-2 study (1999) (1470)
- The Study on Cognition and Prognosis in the Elderly (SCOPE): principal results of a randomized double-blind intervention trial (2003) (1433)
- Reversal of left ventricular hypertrophy in hypertensive patients. A metaanalysis of 109 treatment studies. (1992) (986)
- Randomised trial of effects of calcium antagonists compared with diuretics and β-blockers on cardiovascular morbidity and mortality in hypertension: the Nordic Diltiazem (NORDIL) study (2000) (950)
- Principal results of the Controlled Onset Verapamil Investigation of Cardiovascular End Points (CONVINCE) trial. (2003) (723)
- Hypertension is related to cognitive impairment: a 20-year follow-up of 999 men. (1998) (656)
- Blood pressure dependent and independent effects of antihypertensive treatment on clinical events in the VALUE Trial (2004) (612)
- 1999 World Health Organization-International Society of Hypertension Guidelines for the management of hypertension. Guidelines sub-committee of the World Health Organization. (1999) (557)
- Calcium Antagonist Lacidipine Slows Down Progression of Asymptomatic Carotid Atherosclerosis: Principal Results of the European Lacidipine Study on Atherosclerosis (ELSA), a Randomized, Double-Blind, Long-Term Trial (2002) (528)
- Renal function and intensive lowering of blood pressure in hypertensive participants of the hypertension optimal treatment (HOT) study. (2001) (499)
- 1993 Guidelines for the Management of Mild Hypertension: Memorandum From a World Health Organization/ International Society of Hypertension Meeting (1993) (348)
- Risk factors associated with alterations in carotid intima—media thickness in hypertension: baseline data from the European Lacidipine Study on Atherosclerosis (1998) (308)
- Morbidity and mortality in the Swedish trial in old patients with hypertension (STOP-hypertension). Commentary (1992) (268)
- The relevance of tissue angiotensin-converting enzyme: manifestations in mechanistic and endpoint data. (2001) (267)
- Comparison of antihypertensive treatments in preventing cardiovascular events in elderly diabetic patients: results from the Swedish Trial in Old Patients with Hypertension–2 (2000) (222)
- Baseline Characteristics and Early Blood Pressure Control in the CONVINCE Trial (2001) (218)
- Study on COgnition and Prognosis in the Elderly (SCOPE). (2000) (204)
- PROLONGED EXPOSURE TO A STRESSFUL STIMULUS (NOISE) AS A CAUSE OF RAISED BLOOD-PRESSURE IN MAN (1977) (172)
- Blood pressure crisis following withdrawal of clonidine (Catapres, Catapresan), with special reference to arterial and urinary catecholamine levels, and suggestions for acute management. (1973) (168)
- The 1993 guidelines for the management of mild hypertension: memorandum from a WHO/ISH meeting. (1993) (165)
- Capsaicin-induced cough in humans. (1992) (161)
- Effects of individual risk factors on the incidence of cardiovascular events in the treated hypertensive patients of the Hypertension Optimal Treatment Study. HOT Study Group. (2001) (160)
- The Hypertension Optimal Treatment study and the importance of lowering blood pressure. (1999) (157)
- 1993 guidelines for the management of mild hypertension: memorandum from a WHO/ISH meeting. (1993) (152)
- Neurophysiology of the cough reflex. (1996) (138)
- CORONARY HEART-DISEASE AFTER TREATMENT OF HYPERTENSION (1978) (137)
- Home blood pressure determination. Value in borderline ("labile") hypertension. (1974) (136)
- Pathophysiologic and Therapeutic Importance of Tissue ACE: A Consensus Report (2002) (134)
- Benefits and risks of more intensive blood pressure lowering in hypertensive patients of the HOT study with different risk profiles: does a J-shaped curve exist in smokers? (2003) (133)
- Hemodynamic effects of acute and prolonged beta-adrenergic blockade in essential hypertension. (2009) (129)
- Effects of Clonidine Withdrawal: Possible Mechanisms and Suggestions for Management (1973) (124)
- Serotoninergic mechanisms in hypertension. Focus on the effects of ketanserin. (1988) (119)
- Relation of central hemodynamics to obesity and body fat distribution. (1992) (110)
- Relation between drug treatment and cancer In hypertenslves in the Swedish Trial in Old Patients with Hypertension 2: a 5-year, prospective, randomised, controlled trial (2001) (106)
- Influence of gender and age on preventing cardiovascular disease by antihypertensive treatment and acetylsalicylic acid. The HOT study (2000) (104)
- The Study on COgnition and Prognosis in the Elderly (SCOPE); outcomes in patients not receiving add-on therapy after randomization (2004) (101)
- Regional haemodynamic effects of endothelin-1 in rat and man: unexpected adverse reaction. (1990) (101)
- Protocol for prospective collaborative overviews of major randomized trials of blood-pressure-lowering treatments. World Health Organization-International Society of Hypertension Blood Pressure Lowering Treatment Trialists' Collaboration. (1998) (99)
- Effects of calcium antagonists on the risks of coronary heart disease, cancer and bleeding (1997) (98)
- Noise as a contributory factor in the development of elevated arterial pressure. A study of the mechanisms by which noise may raise blood pressure in man. (2009) (96)
- Summary of 1993 World Health Organisation-International Society of Hypertension guidelines for the management of mild hypertension. Subcommittee of WHO/ISH Mild Hypertension Liaison committee. (1993) (95)
- Hypertensive retinal vascular changes: relationship to left ventricular hypertrophy and arteriolar changes before and after treatment. (1992) (94)
- Low-dose aspirin does not interfere with the blood pressure-lowering effects of antihypertensive therapy. (2002) (90)
- Rationale and design for the Controlled ONset Verapamil INvestigation of Cardiovascular Endpoints (CONVINCE) Trial. (1998) (89)
- VALUE trial: Long-term blood pressure trends in 13,449 patients with hypertension and high cardiovascular risk (2003) (88)
- The Hypertension Optimal Treatment (HOT) Study--patient characteristics: randomization, risk profiles, and early blood pressure results. (1994) (88)
- Characteristics of 15314 Hypertensive Patients at High Coronary Risk. The VALUE Trial (2001) (86)
- Benefit and harm of low-dose aspirin in well-treated hypertensives at different baseline cardiovascular risk (2002) (85)
- Antihypertensive efficacy and side effects of three beta‐blockers and a diuretic in elderly hypertensives: a report from the STOP‐Hypertension study (1992) (82)
- Effect of noise on blood pressure and 'stress' hormones. (1982) (80)
- Risk assessment and treatment benefit in intensively treated hypertensive patients of the Hypertension Optimal Treatment (HOT) study (2001) (78)
- Hypertension optimal treatment (HOT) study: home blood pressure in treated hypertensive subjects. (1998) (77)
- IMMUNOLOGICAL CHANGES IN PATIENTS WITH PREVIOUS MALIGNANT ESSENTIAL HYPERTENSION (1981) (77)
- Beta-adrenergic blockade in essential hypertension. Effects of propranolol on hemodynamic parameters and plasma renin activity. (1973) (77)
- The benefits of lowering elevated blood pressure: a critical review of studies of cardiovascular morbidity and mortality in hypertension. (1996) (77)
- Effects of a perindopril-based blood pressure lowering regimen on cardiac outcomes among patients with cerebrovascular disease. (2003) (74)
- Effects of individual risk factors on the incidence of cardiovascular events in the treated hypertensive patients of the Hypertension Optimal Treatment Study (2001) (73)
- Regional sensitivity of human airways to capsaicin-induced cough. (1992) (72)
- Controlled Trial of Nifedipine and Bendroflumethiazide in Hypertension (1983) (71)
- Controlled study of atenolol in treatment of hypertension. (1975) (69)
- Treatment of hypertension with propranolol and hydralazine. (2009) (67)
- Circulatory effects of noise. (2009) (64)
- Study on COgnition and Prognosis in the Elderly (SCOPE): Baseline Characteristics (2000) (64)
- Regression of left ventricular hypertrophy--a meta-analysis. (1992) (63)
- Bronchodilation by an inhaled VPAC2 receptor agonist in patients with stable asthma (2003) (63)
- Excess Morbidity and Cost of Failure to Achieve Targets for Blood Pressure Control in Europe (2002) (63)
- Malignant hypertension--improving prognosis in a rare disease. (2009) (63)
- Blood pressure lowering for the secondary prevention of stroke: rationale and design for PROGRESS (1996) (62)
- Rationale for combination therapy. (1987) (61)
- Haemodynamic effects of metoprolol and pindolol: a comparison in hypertensive patients. (1982) (56)
- Relation of maternal blood pressure during pregnancy to birth weight and blood pressure in children. The Hypertension in Pregnancy Offspring Study (1994) (56)
- Haemodynamic effects of carvedilol, a new beta-adrenoceptor blocker and precapillary vasodilator in essential hypertension. (1984) (55)
- Regression of left ventricular hypertrophy in previously untreated essential hypertension: different effects of enalapril and hydrochlorothiazide (1992) (55)
- Reversal of cardiovascular structural changes when treating essential hypertension. The importance of the renin-angiotensin-aldosterone system. (1992) (54)
- ACE inhibition preserves renal function better than beta-blockade in the treatment of essential hypertension. (1995) (53)
- An international co-operative study on the relation of blood pressure to electrolyte excretion in populations. I. design and methods (1986) (53)
- VALUE trial: Long-term blood pressure trends in 13,449 patients with hypertension and high cardiovascular risk. (2004) (52)
- Propranolol therapy in essential hypertension. Observations on predictability of therapeutic response. (1974) (52)
- Effects of blood pressure reduction on the structural vascular abnormality in skin and muscle vascular beds in human essential hypertension. (1976) (49)
- Health economics in the Hypertension Optimal Treatment (HOT) study: costs and cost‐effectiveness of intensive blood pressure lowering and low‐dose aspirin in patients with hypertension (2003) (47)
- Effects of formoterol (Oxis Turbuhaler) and ipratropium on exercise capacity in patients with COPD. (2002) (47)
- Cognitive Function and Health-Related Quality of Life in Elderly Patients with Hypertension - Baseline Data from the Study on COgnition and Prognosis in the Elderly (SCOPE) (2002) (46)
- The Hypertension Optimal Treatment (HOT) Study: 12-month data on blood pressure and tolerability. With special reference to age and gender. (1995) (46)
- Hypertension in polycystic kidney disease. (1974) (45)
- Twice-daily propranolol treatment for hypertension. (1971) (44)
- The influence of antihypertensive therapy on the structural arteriolar changes in essential hypertension: different effects of enalapril and hydrochlorothiazide (1993) (43)
- Inhaled nicotine in humans: effect on the respiratory and cardiovascular systems. (1994) (42)
- Circulatory effects of stress in essential hypertension. (2009) (42)
- The Hypertension Optimal Treatment (HOT) Study: 24-month data on blood pressure and tolerability. (1997) (41)
- 1989 guidelines for the management of mild hypertension: memorandum from a WHO/ISH meeting. (1989) (41)
- Headache in mild-to-moderate hypertension and its reduction by irbesartan therapy. (2000) (40)
- Increased secretion of immunoglobulins in malignant hypertension (1989) (39)
- International Society and Federation of Cardiology: Working Group on Classification of Calcium Antagonists for Cardiovascular Disease. (1987) (39)
- Effects of inhaled lignocaine and adrenaline on capsaicin-induced cough in humans. (1994) (38)
- Results of the Controlled ONset Verapamil INvestigation of Cardiovascular Endpoints (CONVINCE) trial by geographical region (2005) (38)
- Prediction of later hypertension following a hypertensive pregnancy. (1983) (38)
- Characteristics of 15,314 hypertensive patients at high coronary risk. The VALUE trial. The Valsartan Antihypertensive Long-term Use Evaluation. (2001) (38)
- ‘WHY DON'T YOU DO AS I TELL YOU?’ COMPLIANCE AND ANTIHYPERTENSIVE REGIMENS (2002) (37)
- Primary Hypertension Refractory to Triple Drug Treatment: A Study on Central and Peripheral Hemodynamics (1978) (37)
- Long-term effects of losartan on blood pressure and left ventricular structure in essential hypertension. (1996) (37)
- Pharmacokinetic and pharmacodynamic parameters in patients treated with nitrendipine. (1983) (37)
- Influence of age, sex and blood pressure on the principal endpoints of the Nordic Diltiazem (NORDIL) Study (2002) (36)
- Experience with nitrendipine--a new calcium antagonist--in hypertension. (1982) (34)
- Influence of sex on blood pressure and left ventricular mass in adolescents: the Hypertension in Pregnancy Offspring Study. (1993) (34)
- Influence of gender and age on preventing cardiovascular disease by antihypertensive treatment and acetylsalicylic acid. The HOT study. Hypertension Optimal Treatment. (2000) (34)
- Oxygen desaturation during sleep and exercise in patients with interstitial lung disease. (1987) (33)
- Predictors of stroke in the elderly. (2009) (33)
- Regional sensitivity of the respiratory tract to stimuli causing cough and reflex bronchoconstriction. (1991) (32)
- Blood pressure reduction and vascular adaptation. A study on long-term effects of treatment with mefruside or atenolol. (2009) (32)
- Effect of coffee on ambulatory blood pressure in patients with treated hypertension (1993) (32)
- Acute and Long‐Term Hemodynamic Effects of Carvedilol, a Combined &bgr;‐Adrenoceptor Blocking and Precapillary Vasodilating Agent, in Hypertensive Patients (1987) (32)
- The optimal blood pressure reduction (1996) (31)
- Hypertension in the elderly. Hypertension seminars at Ostra Hospital, Göteborg, Sweden. (2009) (30)
- Enhanced pressor responses to experimental and daily‐life stress in borderline hypertension (1995) (30)
- Factors affecting the validity of the standard blood pressure cuff. (1993) (30)
- Haemodynamic effects of noise exposure before and after beta 1-selective and non-selective beta-adrenoceptor blockade in patients with essential hypertension. (1981) (29)
- Hemodynamic and hormonal changes induced by noise. (2009) (29)
- Nocturnal hypoxaemia in severe scoliosis. (1988) (28)
- Changes in transcutaneous PCO2 with sleep in normal subjects and in patients with chronic respiratory diseases. (1987) (28)
- Antihypertensive mechanism of beta-adrenoceptor antagonism--the role of beta 2-blockade. (1983) (26)
- The reliability of auscultatory measurement of arterial blood pressure. A comparison of the standard and a new methodology. (1990) (26)
- Effect of nedocromil sodium on the airway response to inhaled capsaicin in normal subjects. (1988) (26)
- Five‐year follow‐up of blood pressure and left ventricular mass in children with different maternal histories of hypertension: the Hypertension in Pregnancy Offspring Study (1994) (26)
- Ketanserin in hypertension. Early clinical evaluation and dose finding study of a new 5-HT2 receptor antagonist. (2009) (26)
- How far should blood pressure be lowered? What is the role of the J-curve? (1990) (24)
- Initial clinical experience with I.C.I. 66.082, a new beta-adrenergic blocking agent, in hypertension. (2009) (24)
- The effects of nitrazepam and flunitrazepam on oxygen desaturation during sleep in patients with stable hypoxemic nonhypercapnic COPD. (1989) (23)
- Left ventricular hypertrophy and myocardial ischaemia in hypertension: the THAMES Study. (1993) (23)
- Antihypertensive treatment and the prevention of dementia: further insights from the Syst-Eur trial. (1999) (23)
- Antihypertensive Effect of Felodipine or Hydralazine When Added to β‐Blocker Therapy (1988) (23)
- Antihypertensive Treatment: Does the J-curve Exist? (2000) (22)
- Blood pressure does not predict mortality in the elderly (1988) (22)
- Long-term hypotensive effect of atenolol (ICI 66.082), a new beta-adrenergic blocking agent. (2009) (22)
- CLINICAL ASPECTS OF BLOOD PRESSURE CRISIS DUE TO WITHDRAWAL OF CENTRALLY ACTING ANTIHYPERTENSIVE DRUGS (1983) (22)
- Remikiren (Ro 42-5892)--an orally active renin inhibitor in essential hypertension. Effects on blood pressure and the renin-angiotensin-aldosterone system. (1996) (22)
- How much should blood pressure be lowered? The problem of the J-shaped curve. (1989) (21)
- Calcium antagonists combined with beta-blockers or ACE inhibitors in the treatment of hypertension. (1988) (21)
- Labetalol, a new alpha- and beta-adrenoreceptor blocking agent, in hypertension. (1976) (21)
- Blood pressure and left ventricular mass in children with different maternal histories of hypertension: the Hypertension in Pregnancy Offspring Study (1993) (20)
- Urinary kallikrein excretion is low in malignant essential hypertension. (1992) (20)
- Propranolol in hypertension (1972) (20)
- Antihypertensive effect of a new dihydropyridine calcium antagonist, PN 200-110 (isradipine), combined with pindolol. (1987) (19)
- Additive effect of isradipine in combination with captopril in hypertensive patients. (1989) (19)
- Underestimation of the true benefits of antihypertensive treatment: an assessment of some important sources of error. (1997) (19)
- Improved accuracy of indirect blood pressure measurement in patients with obese arms. (1993) (18)
- Abnormal immune function in malignant hypertension (1993) (18)
- Treatment of Hypertension With β‐Blockers With and Without Intrinsic Sympathomimetic Activity (1983) (18)
- Results of the STOP-Hypertension-2 trial. (2000) (18)
- Hypertension management in 2002: where have we been? where might we be going? (2002) (17)
- IX - 1993 Guidelines for management of mild hypertension. Memorandum from a WHO/ISH meeting (1993) (17)
- Interrelation of cardiac and vascular structure in young men with borderline hypertension. (1993) (17)
- Hypertension Optimal Treatment (HOT) trial (1998) (17)
- Comparison of guanadrel and guanethidine (1973) (17)
- Borderline hypertension. Hypertension seminars at Ostra Hospital, Göteberg, Sweden. (2009) (17)
- What are we really achieving with long-term drug therapy? (1988) (17)
- Losartan in essential hypertension: Effects on blood pressure and left ventricular maass (1995) (16)
- Different Haemodynamic Reaction Patterns during Noise Exposure in Normotensive Subjects with and without Heredity for Essential Hypertension (1982) (16)
- The E.L.S.A. Trial: Protocol of a Randomized Trial to Explore the Differential Effect of Antihypertensive Drugs on Atherosclerosis in Hypertension (1994) (16)
- Metoprolol and pindolol in hypertension: different effects on peripheral haemodynamics. (1981) (16)
- Glucose and insulin levels in young subjects with different maternal histories of hypertension: The Hypertension in Pregnancy Offspring Study (1997) (15)
- Human leucocyte antigens in patients with previous essential malignant hypertension. (1980) (15)
- Calcium Antagonists in Hypertension: Update 1986 (1987) (15)
- Cardiovascular responses to stress in young hypertensive women. (1992) (15)
- Long-term renal preservation in essential hypertension: Angiotensin converting enzyme inhibition is superior to β-blockade☆ (1996) (15)
- Morbidity and mortality with dihydropyridines. (1998) (15)
- Review of state-of-the-art beta-blocker therapy. (1991) (14)
- Prevention of hypertension and associated cardiovascular disease: a 1991 statement. Conclusions from a joint WHO/ISH meeting. (1992) (14)
- 23 ELSA, European Lacidipine Study on Atherosclerosis (1993) (14)
- Stress and platelet activation. (1983) (14)
- Fosinopril versus enalapril in the treatment of hypertension: a double-blind study in 195 patients. (1996) (14)
- Future goals for the treatment of hypertension in the elderly with reference to STOP-Hypertension, SHEP, and the MRC trial in older adults. (1993) (14)
- Beta-adrenergic blockade in hypertension. (1977) (14)
- Renal aspects of the Hypertension Optimal Treatment (HOT) Study (1996) (14)
- Effect of high dose spironolactone and chlorthalidone in essential hypertension: relation to plasma renin activity and plasma volume. (1975) (14)
- The Relationship between Dose and Antihypertensive Effect for Different AT 1 -receptor Blockers (2001) (13)
- Vasodilators in hypertension--a review with special emphasis on the combined use of vasodilators and beta-adrenoceptor blockers. (1985) (13)
- Results of the STOP-Hypertension-2 Trial (2000) (13)
- The incidence of ECG abnormalities in acute cerebrovascular accidents. (2009) (13)
- 1999 World Health Organization-International Society of Hypertension Guidelines for the Management of Hypertension endorsed by the Lebanese Hypertension League (1999) (13)
- Effects of treatment with nifedipine and metoprolol in essential hypertension (2004) (13)
- Homocysteine and ADMA--emerging risk factors for cardiovascular disease? (2002) (13)
- Captopril and atenolol combined with hydrochlorothiazide in essential hypertension. (1982) (13)
- Therapy of hypertension and metabolic syndrome: today's standard and tomorrow's perspectives. (1998) (12)
- Blood pressure over-shoot due to acute clonidine (Catapres) withdrawal: studies on arterial and urinary catecholamines and suggestions for management of the crisis. (1973) (12)
- Correspondence between screening and intra‐arterial blood pressures in young men with borderline hypertension (1993) (12)
- Recent intervention trials in hypertension initiated in Sweden--HOT, CAPPP and others. Hypertension Optimal Treatment Study. Captopril Prevention Project. (1999) (12)
- Regression of structural cardiovascular changes by antihypertensive therapy. (1984) (12)
- Controlled trial of enalapril and hydrochlorothiazide in 200 hypertensive patients. (1988) (12)
- Acute haemodynamic effects of carvedilol (BM 14190), a new combined beta-adrenoceptor blocker and precapillary vasodilating agent, in hypertensive patients (2004) (11)
- The use of propranolol in hypertension: a review. (1976) (11)
- Hemodynamics of prehypertension and hypertension. (1974) (11)
- Renal function as an indicator of prognosis in malignant essential hypertension. (1982) (11)
- VIEWPOINT The Antiatherosclerotic Effect of Calcium Antagonists in Man—What did MIDAS Actually Show? (1995) (11)
- Calcium Antagonists in Antihypertensive Combination Therapy (1991) (11)
- Carvedilol in the treatment of hypertension--a review of the clinical data base. (1998) (11)
- Assessment of Hypertensive Organ Damage (1997) (11)
- Calcium antagonists in the treatment of hypertension: state of the art. (1990) (10)
- Hypertension in pregnancy. Analysis of 261 consecutive cases. (1986) (10)
- REGRESSION OF LEFT VENTRICULAR HYPERTROPHY (1992) (10)
- Long-term experience with the combination of pindolol and isradipine in essential hypertension (1988) (10)
- Characteristics of Hypertension in Pregnancy (1984) (10)
- Long-term effects of captopril and atenolol in essential hypertension. (2009) (10)
- Estrogen and progestagen modify the hemodynamic response to mental stress in young women (1996) (10)
- Maternal hypertension during pregnancy and high blood pressure in children. Preliminary communication. (1983) (10)
- HAPPHY trial: primary prevention against coronary heart disease with beta-blockers ruled out by HAPPHY? (1987) (10)
- Predictors of blood pressure and left ventricular mass in the young: the Hypertension in Pregnancy Offspring Study. (1994) (10)
- Mode of action of beta-adrenoceptor blocking agents in hypertension. A comparison between metoprolol and pindolol with special reference to peripheral vascular effects. (2009) (9)
- Success in the treatment of hypertension: a status report. (1997) (9)
- Haemodynamic effects of loud noise in hypertensive patients treated with combined beta-adrenoceptor blockade and precapillary vasodilatation. (1984) (9)
- The antiatherosclerotic effect of calcium antagonists in man--what did MIDAS actually show? Multicenter Isradipine Diuretic Atherosclerosis Study. (1995) (9)
- Acute haemodynamic effects of carvedilol (BM 14190), a new combined beta-adrenoceptor blocker and precapillary vasodilating agent, in hypertensive patients (2004) (9)
- Blood Pressure Measurement: A Century of Achievements and Improvements in the Year 2002 (2002) (9)
- Hypotensive action of ICI66.082, a new beta-adrenergic blocking agent. (1974) (9)
- A comparison of the antihypertensive effect of atenolol (ICI 66 082) and propranolol (1976) (9)
- Regression of Structural Alterations of Hypertension with Calcium Antagonists - Vascular Hypertrophy (1987) (9)
- Reversal of cardiac and vascular hypertrophy by antihypertensive therapy. (1991) (9)
- Current and future strategies in the treatment of hypertension. (1988) (9)
- Potentiation of the antihypertensive effect of enalapril by randomized addition of different doses of hydrochlorothiazide. (1985) (8)
- The Captopril Prevention Project (CAPPP): description and status. (1994) (8)
- Swedish Isradipine Study in Hypertension: Evaluation of Quality of Life, Safety, and Efficacy (1991) (8)
- Borderline hypertension. A 24-hour abnormality. (1993) (8)
- Calcium antagonists: an overview. (1991) (8)
- Effect of Sar1-ala8-angiotensin II on blood pressure and renin in Bartter's syndrome, before and after treatment with prostaglandin synthetase inhibitors. (1979) (8)
- Treatment of Hypertension and the J Curve. (1999) (8)
- Study on COgnition and Prognosis in the Elderly (SCOPE): Design and Objectives (2000) (8)
- Hemodynamics of metoprolol and pindolol in systemic hypertension with particular reference to reversal of structural vascular changes. (1986) (8)
- Arterial hypotension and its consequences for the cerebral circulation. (2009) (8)
- The place of β-blockers in the treatment of hypertension in 1993 (1993) (7)
- How far Should we Lower Blood Pressure in the Elderly (2004) (7)
- Possible relationship between psycho-emotional factors and haemodynamic patterns in the pathogenesis of mild blood pressure elevation. (1981) (7)
- Blood pressure and response to "stress" in 11-16 year old children. (2009) (7)
- PROGRESS – perindopril protection against recurrent stroke study: status in July 1996 (1996) (7)
- Beta-blockers with ACE inhibitors--a logical combination? (1989) (7)
- Cerebrovascular lesions. Active antihypertensive treatment and the present situation. (2009) (6)
- Heart rate responses during treatment of hypertension with propranolol; The clinical usefulness of the nitroglycerin test (1976) (6)
- Hemodynamic effects of combined beta-adrenoceptor blockade and precapillary vasodilatation in hypertension. (2009) (6)
- Clinical studies with candesartan. (1999) (6)
- 1991 Guidelines for the prevention of hypertension and associated cardiovascular disease (1992) (6)
- Long-term renal preservation in essential hypertension. Angiotensin converting enzyme inhibition is superior to beta-blockade. (1996) (6)
- Captopril or atenolol in essential hypertension. (2009) (6)
- Comparison of Home and Office Blood Pressure in Treated Hypertensives in the Nordic Diltiazem (NORDIL) Study (2002) (6)
- Evaluation of endpoints in hypertension. (1997) (6)
- The key issues in preventive cardiology. (1992) (6)
- Antihypertensive effect of labetalol, a new alpha- and beta-adrenergic blocking agent. (1976) (6)
- Hypertension and coronary heart disease: cause and consequence or associated diseases? (1984) (6)
- Cardiac involvement in hypertension (1982) (5)
- ADVANTAGES AND DISADVANTAGES OF THE META-ANALYSIS APPROACH. DISCUSSION (1996) (5)
- Improved blood pressure control with isradipine in hypertensive patients treated with pindolol. (1989) (5)
- Prevention of coronary heart disease: the recommendations of the European Society of Cardiology, European Atherosclerosis Society and European Society of Hypertension. (1995) (5)
- Assessment of the patient's response. (1985) (5)
- Cardiac involvement in hypertension. A non-invasive study of patients with previous malignant hypertension and 'benign' hypertension. (1982) (5)
- Primary hypertension refractory to triple drug treatment - a study on central and peripheral hemodynamics. (2009) (5)
- A Clinical Follow-Up Study of 260 Women with Hypertension in Pregnancy (1983) (5)
- Review of studies with urapidil in elderly hypertensives. (1995) (5)
- Positive Relationship Between the Dosage of Pindolol and Its Antihypertensive Effect (1982) (5)
- Addition of the calcium antagonist PN 200-110 to pindolol markedly augments the antihypertensive effect in essential hypertension. (1987) (4)
- The Effect of Dihydropyridine Calcium Antagonists in Hypertensive Patients with Impaired Renal Function (1989) (4)
- THE VALSARTAN ANTIHYPERTENSIVE LONGTERM USE EVALUATION (VALUE) TRIAL: FINAL PATIENTS DEMOGRAPHICS (2000) (4)
- Capsaicin-induced Cough in Humans 1 • 2 (1992) (4)
- First-line antihypertensive therapy [letter] (2000) (4)
- Pafenolol in Hypertension: A Double-Blind Randomized Trial of a New β1-Selective Adrenoceptor Blocker (1986) (4)
- Is blood pressure measurement with a standard cuff reliable? (1992) (4)
- Cerebrovascular risk factors are determinants of low cognitive function: A 20-year follow-up of 999 elderly men (1999) (4)
- Implications of doxazosin therapy on risk of coronary heart disease. (1988) (4)
- [The long-term treatment of hypertension in 158 patients with propranonol]. (1971) (4)
- First-line antihypertensive therapy (2000) (4)
- Effects of angiotensin-converting enzyme inhibition versus conventional antihypertensive therapy on the glomerular filtration rate. (1995) (4)
- The long-term effect of isradipine in pindolol-treated patients. (1987) (4)
- Clinical evaluation of atenolol in hypertension. (1976) (4)
- European Society of Hypertension Scientific Newsletter, Update on Hypertension Management: Treatment of hypertension in patients with type‐2 diabetes mellitus (2000) (4)
- International views of the use of calcium antagonists in the treatment of hypertension. (1985) (4)
- Negative consequences of blood pressure reduction. (2009) (4)
- Effects of single doses of propiomazine, a phenothiazine hypnotic, on sleep and oxygenation in patients with stable chronic obstructive pulmonary disease. (1990) (4)
- Treatment of hypertension in the elderly with special reference to urapidil. (1994) (4)
- Blockers in Hypertension (1987) (4)
- Mechanisms in hypertension : new aspects in hemodynamics (1989) (3)
- [Stimulation of the sinus nerves with an implanted baropacer in patients with therapy-resistant hypertension]. (1973) (3)
- 88 The Hypertension Optimal Treatment (HOT) study purpose and design (1993) (3)
- A clinical follow-up study of 260 women with hypertension in pregnancy. (1984) (3)
- THE EFFECT OF PROPRANOLOL ON PLASMA RENIN ACTIVITY AND BLOOD PRESSURE IN MILD ESSENTIAL HYPERTENSION (2009) (3)
- The place of beta-blockers in the treatment of hypertension in 1993. (1993) (3)
- ISA--vasodilatation: improvement of organ perfusion. (1987) (3)
- NEUROPHYSIOLOGY OF THE COUGH REFLEX. AUTHOR'S REPLY (1996) (3)
- Hypertension-induced congestive heart failure. (1998) (3)
- Blood pressure and serum lipids in hypertensive men and women aged 60-97 years. (1995) (3)
- Isolated systolic hypertension (1987) (3)
- Hypertension in the elderly (1996) (3)
- Cardioprotective potential of antihypertensives. (1995) (3)
- A double-blind comparison of spironolactone and hydrochlorothiazide in hypertensive patients treated with metoprolol. (1982) (3)
- Hypertension in the elderly: state-of-the-art treatment. (1998) (3)
- Risk of major gastrointestinal bleeding with aspirin (1999) (3)
- Antihypertensive Effect of Prizidilol (1983) (3)
- What have we learned from the HOT (Hypertension Optimal Treatment) study? (1997) (3)
- EDITORIAL The growing importance of systolic blood pressure (1998) (3)
- Shortcomings of current antihypertensive therapy. (1991) (3)
- INSIGHT and NORDIL (2000) (3)
- Beta-Adrenoceptor Blocking Drugs As Antihypertensive Agents (1982) (3)
- Isradipine: a profile in essential hypertension (1993) (3)
- The Rationale for Ketanserin Therapy in Hypertension (1987) (3)
- HYPERTENSION OPTIMAL TREATMENT (HOT) TRIAL. AUTHORS' REPLY (1998) (3)
- The future role of losartan. (1995) (3)
- Relationship between change in erythrocyte sodium and antihypertensive response to enalapril. (1994) (2)
- Analysis of treatment outcomes. Why is benefit not larger? (1989) (2)
- Factors in the selection of a new antihypertensive and anti‐anginal drug (1988) (2)
- Combined treatment of hypertension with vasodilatation and beta-adrenergic blockade. (1973) (2)
- HANDBOOK OF HYPERTENSION (1984) (2)
- Introduction: Position of beta blockers in antihypertensive therapy (1986) (2)
- Dissociation of the renin lowering and antihypertensive actions of propranolol. (1976) (2)
- 95. Haemodynamic stress responses in hypertensive women during the menstrual cycle (1991) (2)
- Treatment of hypertension in patients with type-2 diabetes mellitus. (2000) (2)
- Major antihypertensive intervention trials conducted outside the United States. (1996) (2)
- Position of beta blockers in antihypertensive therapy. (1986) (2)
- Key learnings from the STOP-Hypertension study: An update on the progress of the ongoing Swedish study of antihypertensive treatment in the elderly (2004) (2)
- Introduction: the role of combination therapy in modern antihypertensive therapy. (2000) (2)
- Treatment of Hypertension in the Elderly (1993) (2)
- Medical and cost-economy aspects of modern antihypertensive therapy--with special reference to 2 years of clinical experience with losartan. (1997) (2)
- Prevention of hypertension and associated cardiovascular disease. A 1995 statement. Conclusions from a joint WHO/ISH Meeting. (1996) (2)
- Endothelial Dysfunction - A Challenge for Hypertension Research (2000) (2)
- Pre‐eclampsia, hypertension and the premenstrual tension syndrome (1990) (2)
- Effects of beta-adrenoceptor blocking agents on haemodynamic parameters. (2009) (2)
- Does drug treatment improve survival in mild-to-moderate hypertension? (1995) (2)
- Status of current therapies for hypertension. (1995) (2)
- Low erythrocyte Na+/K+ ratio in children with mild blood pressure elevation and a positive family history of hypertension. (1984) (2)
- Antihypertensive therapy-a viable branch of medicine and Obituary (1997) (2)
- Concluding Remarks (1999) (2)
- What does STOP-2 tell us about management of hypertension? (2000) (2)
- Cardiovascular risk factors and antihypertensive treatment. (1992) (2)
- Aims of Treatment of Hypertension (1987) (2)
- On Salt and Treatment Goals in Hypertension: Time for Reappraisal? (1992) (2)
- J curve relation between diastolic blood pressure and myocardial infarction. (1989) (1)
- Mortality matters. (1994) (1)
- Hypertensive therapy--effect on coronary risk factors. (1992) (1)
- Strong evidence that antihypertensive pharmacologica treatment reduces cardiovascular morbidity and mortality (1999) (1)
- MICROALBUMINURIA IN ESSENTIAL HYPERTENSION AND DIABETES MELLITUS. DISCUSSION (1996) (1)
- Issues in the treatment of hypertension: current and future perspectives. (1997) (1)
- [Effect of intensive antihypertensive treatment and of aspirin in a low dose in the hypertensive. The HOT (Hypertension Optimal Treatment) study]. (1999) (1)
- The impact of antihypertensive therapy in type 2 diabetes (2000) (1)
- [Vascular surgery or amputation in critical extremity ischemia?]. (1988) (1)
- The J-shaped curve and how far should blood pressure be lowered? (1995) (1)
- Circulatory aspects of hypertension. Hypertension seminars at Ostra Hospital, Göteborg, Sweden. (2009) (1)
- Vasodilatation and beta-adrenoceptor blockade in hypertension: A double-blind comparison between prizidilol and propranolol plus hydralazine (1983) (1)
- Methodological aspects: general discussion (1996) (1)
- Adrenergic agents: clinical trials and experiences. (1992) (1)
- P-453 *Program Revision (see p. 267A): Gender specific characteristics of 15,288 hypertensive patients at high coronary risk. The value trial (2001) (1)
- Is Hypertension Treated Adequately? (2012) (1)
- Antipathological potential of beta-blockers. (1989) (1)
- Treatment of hypertension in the elderly. (1993) (1)
- ACE Inhibitor as One of Several Possible First-Line Agents Is Reasonable for Diabetic Patients With Hypertension (2002) (1)
- Influence of age and gender on preventing myocardial infarction by antihypertensive treatment and aspirin in the hot study. (1999) (1)
- How far should blood pressure be lowered? What is the importance of the J-curve phenomenon? (1990) (1)
- Predicted reductions in the risk of coronary heart disease by antihypertensive therapy: the confounding effect of lipids (1990) (1)
- Failure of randomisation by “sealed” envelope (1999) (1)
- Beta‐blockers and related drugs for the treatment of hypertension (1988) (1)
- How to study the role of hypertension in atherosclerosis. Lessons from MIDAS. Multicentre Isradipine Diuretic Atherosclerosis Study. (1996) (1)
- Peripheral vascular changes after treatment of severe hypertension (1982) (1)
- Combination therapy with saluretics and atenolol in essential hypertension. Effects on blood pressure, electrolytes and uric acid. (2009) (1)
- "Stress" and hypertension. (2009) (1)
- Sympathetic nervous system: The link between heart failure, hypertension, and NIDDM: Proceedings from a satellite symposium at the XIXth congress of the European Society of Cardiology (ESC), held in Stockholm, Sweden, August 27, 1997. Introduction (1998) (1)
- Treatment of Hypertension with Calcium Antagonists (1989) (1)
- 152 Additive effect of isradipine in combination with captopril in hypertensive patients (1988) (1)
- The value trial: patients demographics and progress report. (1999) (1)
- A hemodynamic study of arteriolar changes in patients with previous malignant hypertension. (2009) (1)
- The Parathyroid Hypertensive Factor: Important Evidence Is Accumulating (1993) (1)
- 98 The cost-effectiveness of treating hypertension in the elderly: an analysis of the Swedish Trial in Old Patients with Hypertension (STOP-Hypertension) (1993) (1)
- [BBB--a Swedish multicenter study. Can hypertension be better treated?]. (1988) (0)
- The medullipin system of blood pressure control (1997) (0)
- Treatment of isolated systolic hypertension. (1994) (0)
- Prediction of insulin resistance [editorial; comment] (1996) (0)
- Book Review (2002) (0)
- 58 A five-year follow-up after withdrawal of treatment in elderly hypertensives (1993) (0)
- [Review of new pharmacological treatment principles in hypertension]. (1983) (0)
- METHODOLOGICAL ASPECTS : GENERAL DISCUSSION. DISCUSSION (1996) (0)
- Combined Action Drugs in the Treatment of Hypertension (2012) (0)
- Summary of 1993 WHO/ISH guidelines for the management of mild hypertension: memorandum from a WHO/ISH meeting. Guidelines Sub-Committee of WHO/ISH Mild Hypertension Liaison Committee. (1993) (0)
- Headache, Hypertension, and Irbesartan Therapy—Reply (2001) (0)
- The Future of Pharmacological Therapy for Risk Factor Reduction (2012) (0)
- Hypertension guidelines and goals of treatment: role of calcium antagonists. (2000) (0)
- Postmenopausal Hormone Replacement Therapy and Hypertension (2000) (0)
- Monotherapy vs combined treatment in hypertension: new clinical trials data. (2001) (0)
- Satellite Symposium on Do European Hypertensive Patients Get Optimal Treatment? at XXth Congress of the European Society of Cardiology, Vienna, Austria, 22 August 1998: Introduction (1998) (0)
- Choice of initial therapy: new clinical trials data (2002) (0)
- [Hypertensive crises are rare conditions. Uncritical use of intravenous antihypertensive agents can be more harmful than useful]. (1986) (0)
- ACE inhibition and left ventricular remodelling. (1997) (0)
- Letter to the members of the International Society of Hypertension (1989) (0)
- The hypertension optimal study (1998) (0)
- 27. Retinal vascular changes: different effects of enalapril and hydrochlorothiazide in previously untreated patients with non-malignant hypertension (1991) (0)
- 72. Left ventricular mass in children with different maternal background for hypertension (1991) (0)
- Comparison of meta-analyses of therapeutic studies on regression of left ventricular hypertrophy. (1997) (0)
- Reaching BP targets : physicians' flexibility with therapy : based on a satellite symposium held at the XXIst Congress of the European Society of Cardiology, Barcelona, Spain, 28 August 1999 (2000) (0)
- Choosing the optimal antihypertensive dose regimen (1995) (0)
- COST-EFFECTIVENESS CALCULATIONS FROM TRIALS. DISUCUSSION (1996) (0)
- CAPTOPRILAND ATENOLOL COMBINED WITH HYDROCHLOROTHIAZIDE INESSENTIALHYPERTENSION (1982) (0)
- Cognitive function/dementia: Thursday, may 18, broadway ballroom south, 10:30 am to 12:30 pm. theme iii: hypertension: markers, risk factors and outcomes (2000) (0)
- Evaluation of the hypertensive patient (1996) (0)
- 44 STOP-Hypertension 2 (1993) (0)
- Update of the Latest Intervention Trials in Hypertension and Type 2 Diabetes (2000) (0)
- [Round table on Hypertension and coronary heart disease: new trends in treatment]. (1984) (0)
- General Considerations When Treating Hypertension (2012) (0)
- B028: Study on cognition and prognosis in the elderly (SCOPE). evaluation of risk factors (2000) (0)
- Wednesday, 5/17, Trianon, 8:30 am–11:30 am Unresolved Issues in the Treatment of HypertensionNew Trials of Antihypertensive Drugs Outside the United States (1995) (0)
- [Mild hypertension--risks and therapeutic strategies]. (1984) (0)
- 43 A blood pressure fall is not the only factor of importance in the reversal of cardiac hypertrophy (1993) (0)
- Treatment of Hypertension with β-Blockers in Elderly Patients (1982) (0)
- Erythrocyte sodium transport in malignant hypertension (1990) (0)
- Characteristics of an ideal antihypertensive therapy for elderly hypertensives. (1995) (0)
- [Experiences with a portable semi-automatic blood pressure recorder]. (1979) (0)
- 9. Correspondence between screening and intra-arterial blood pressures in young men with borderline hypertension (1991) (0)
- 78. The SWISH study (Swedish Isradipine Study in Hypertension): evaluation of quality of life and efficacy in 587 patients (1991) (0)
- Lessons from STOP-Hypertension (1994) (0)
- D047 Study on cognition and prognosis in the elderly (SCOPE). Design and objectives (1998) (0)
- Impact of antihypertensive drugs on the cardiovascular patient. (1987) (0)
- [Not much news for Sweden in new international hypertension guidelines]. (1990) (0)
- Intermediate cardiovascular end points in therapeutic trials (1997) (0)
- Smoking affects blood pressure [editorial] (1996) (0)
- Researchers Receive Record Compensation from TV Company for Media Insult Linked to the Calcium Antagonist Controversy (2002) (0)
- Editorial: Prediction of insulin resistance (1996) (0)
- D012 Valsartan antihypertensive longterm use evaluation (the value study) (1998) (0)
- Antihypertensive drugs and plasma lipids. (1992) (0)
- 17 Considerable reduction of blood pressure and significant reduction of left ventricular mass when adding isradipine in hypertensive men treated with a beta-blocker (1993) (0)
- POST HOC ANALYSIS : USE AND DANGERS IN PERSPECTIVE. DISCUSSION (1996) (0)
- P-225: Predictors of one year blood pressure control and treatment resistance in the value trial (2002) (0)
- 76 Suppressed male sex steroid hormones in borderline hypertension (1993) (0)
- Hypertension and the heart. Advances in experimental medicine and biology (1997) (0)
- Benefits and risks of treating hypertension in the elderly (1995) (0)
- Treatment of hypertension--risk/benefit: excerpts of a panel discussion. (2009) (0)
- Editorial: Hypertension Management in Practice - Priorities and Problems (1998) (0)
- Beta-blockers in hypertension. (1987) (0)
- Blood pressure and coronary heart disease [editorial; comment] (1999) (0)
- Clinical trials in progress with antihypertensive therapy (1995) (0)
- THE HYPERTENSION TRIALS. DISCUSSION (1996) (0)
- 25. Different effects of enalapril and hydrochlorothiazide on left ventricular structure: a controlled study of untreated hypertensives (1991) (0)
- 134 High blood pressure, but not smoking habits, predicts the risk of stroke in an elderly population (1988) (0)
- THE OPTIMAL BLOOD PRESSURE REDUCTION. DISUCSSION (1996) (0)
- The case for a greater blood pressure fall. (1996) (0)
- CAPPP trial (1999) (0)
- The impcat of systolic blood pressure control in angiotensin II antagonist blockade (2001) (0)
- Blood pressure--then and now [editorial] (1996) (0)
- 87 Cardiovascular morbidity and mortality in the BBB study (1993) (0)
- Antihypertensive therapy--a viable branch of medicine [editorial] (1997) (0)
- BENEFITS AND RISKS OF LOW-DOSE ASPIRIN IN DIFFERENT GROUPS OF HYPERTENSIVE PATIENTS IN THE HOT STUDY: P2.13 (2000) (0)
- Intervention trials in hypertension. An update on the status of ongoing studies (1996) (0)
- The Art of Prediction and Prevention (1994) (0)
- Evaluation of end-points in hypertension (1997) (0)
- [Healthy persons are classified as hypertensive due to faulty equipment for blood pressure determination]. (1989) (0)
- [A review of recent pharmacological therapeutic principles in hypertension]. (1983) (0)
- Current intervention trials with ACE inhibitors in hypertension (1996) (0)
- Modern combination therapy: the way forward in the management of hypertensive patients. Proceedings of an international symposium. Barcelona, Spain, 1-2 November 1996. (1997) (0)
- Evaluation of the hypertensive subject (1990) (0)
- D7 - The “hot” study; a large international prospective trial to evaluate the “J” curve during treatment of hypertension (1995) (0)
- Hypertension Control for a New Era: Emerging Differences among AIIRAs (2001) (0)
- Combination therapy for stroke: Lessons from STOP-Hypertension (1997) (0)
- [Aortic coarctation - a neglected cause of hypertension?]. (1983) (0)
- Dr Lowe has received funding for investigator-initiated (2002) (0)
- Twenty-four hour blood pressure control : Clinical importance, measurement, and antihypertensive efficacy (1997) (0)
- B017: The valsartan antihypertensive longterm use evaluation (VALUE) trial: Final patients demographics (2000) (0)
- Isradipine in Hypertension (2012) (0)
- HYPERTENSIOh IN POLYCY STIC KIDNEY DISEASE (2013) (0)
- The hypertension optimal treatment (hot) study — Home BP in treated hypertensives (1997) (0)
- Book Review (2001) (0)
- INTENSIVE BLOOD PRESSURE LOWERING: CONTRAST BETWEEN BENEFITS IN DIABETICS AND OTHER GROUPS OF HYPERTENSIVE PATIENTS AND INCREASED RISK IN SMOKERS (2000) (0)
- [Does antihypertensive treatment reduce the incidence of coronary disease?]. (1984) (0)
- Update on stop-hypertension (1995) (0)
- Antihypertensive therapy: Efficacy and tolerability in the elderly (1997) (0)
- Blood pressure @ Internet-www.bloodpressure.nu [editorial] (2000) (0)
- Treatment of Hypertension in the Elderly and Its Effect on Stroke (1994) (0)
- [Clinical testing of a new beta blocking agent--atenolol--in hypertension]. (1976) (0)
- CV6: EXCESS MORBIDITY AND COST OF FAILING TO ACHIEVE TARGETS FOR BLOOD PRESSURE CONTROL IN THE ELDERLY (2001) (0)
- Hypertension--interaction with other coronary heart disease risk factors. (1992) (0)
- Report from the First Meeting of the International Forum for Evaluation of Cardiovascular Care (IFECC) in 1990 (1990) (0)
- 92 Five-year tracking of blood pressure and cardiac structures in children with a different maternal background of hypertension: the Hypertension in Pregnancy Offspring Study (1993) (0)
- Long-term benefits of antihypertensive treatment (1998) (0)
- Editorial: Blood Pressure—Then and Now (1996) (0)
- [Various beta-receptor blockaders affect hemodynamics in different ways]. (1982) (0)
- Blood Pressure Risks and Awards (1995) (0)
- Should a modern antihypertensive drug possess cardioprotective properties? (1997) (0)
- Ten years of BLOOD PRESSURE—Looking back and forward (2001) (0)
- The effct of propranolol on plasma renin activity and blood pressure in mild essential hypertension. (1974) (0)
- [Many physicians do not measure blood pressure and do not know their own blood pressure status]. (1980) (0)
- PRINCIPAL RESULTS OF THE NORDIL HYPERTENSION TRIAL – A COMPARISON BETWEEN DILTIAZEM AND DIURETIC/BETABLOCKER BASED TREATMENT: P2.46 (2000) (0)
- 26. Effect of first line antihypertensive therapy on cardiac hypertrophy: a meta-analysis of 1141 patients (1991) (0)
- Antihypertensive effect of atenolol--a Swedish multicentre study. (1977) (0)
- Hypertension and the Heart (1997) (0)
- 67. Reduction in blood pressure and adverse effects in the Behandla Blodtryck Battre Study (1991) (0)
- Current problems in clinical hypertension: summary of a workshop held in Martinique, 29-31 October 1989. (1990) (0)
- The forgotten significance of heart rate in cardiovascular disease : implications of chronotherapeutics : proceedings of a satellite symposium held at the XXth congress of the European Society of Cardiology, Vienna, Austria, 22 August 1998 (1999) (0)
- Treatment of Hypertension in the and Its Effect on Stroke Elderly (2006) (0)
This paper list is powered by the following services: